Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Drosten

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The Journal of Clinical Investigation|March 17, 2023
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomasMarina Salmón, Ruth Álvarez-Díaz, Coral Fustero-Torre, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistanceVasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
EMBO Molecular Medicine|November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutationsIrene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistanceVasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Cancer Cell|April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAFMaría Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The Journal of Clinical Investigation|March 17, 2023
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomasMarina Salmón, Ruth Álvarez-Díaz, Coral Fustero-Torre, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistanceVasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
EMBO Molecular Medicine|November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutationsIrene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistanceVasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Cancer Cell|April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAFMaría Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Pageof 5